CL2020000170A1 - Composición para su uso en la prevención y el tratamiento de patologías del aparato cardiovascular. - Google Patents
Composición para su uso en la prevención y el tratamiento de patologías del aparato cardiovascular.Info
- Publication number
- CL2020000170A1 CL2020000170A1 CL2020000170A CL2020000170A CL2020000170A1 CL 2020000170 A1 CL2020000170 A1 CL 2020000170A1 CL 2020000170 A CL2020000170 A CL 2020000170A CL 2020000170 A CL2020000170 A CL 2020000170A CL 2020000170 A1 CL2020000170 A1 CL 2020000170A1
- Authority
- CL
- Chile
- Prior art keywords
- composition
- diseases
- prevention
- treatment
- cardiovascular system
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 210000000748 cardiovascular system Anatomy 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical class [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 abstract 1
- 159000000003 magnesium salts Chemical class 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 229940088594 vitamin Drugs 0.000 abstract 1
- 229930003231 vitamin Natural products 0.000 abstract 1
- 235000013343 vitamin Nutrition 0.000 abstract 1
- 239000011782 vitamin Substances 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/326—Foods, ingredients or supplements having a functional effect on health having effect on cardiovascular health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/1592—Iron
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
- A23V2250/161—Magnesium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/70—Vitamins
- A23V2250/714—Vitamin K
- A23V2250/7144—Vitamin K2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102017000085412A IT201700085412A1 (it) | 2017-07-26 | 2017-07-26 | Composizione per uso nella prevenzione e nel trattamento di patologie dell'apparato cardiovascolare |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2020000170A1 true CL2020000170A1 (es) | 2020-10-30 |
Family
ID=60451085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2020000170A CL2020000170A1 (es) | 2017-07-26 | 2020-01-20 | Composición para su uso en la prevención y el tratamiento de patologías del aparato cardiovascular. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20200206157A1 (https=) |
| EP (1) | EP3657963A1 (https=) |
| JP (2) | JP2020528888A (https=) |
| KR (1) | KR20200032691A (https=) |
| CN (1) | CN111031813A (https=) |
| BR (1) | BR112020000902B1 (https=) |
| CA (1) | CA3070659A1 (https=) |
| CL (1) | CL2020000170A1 (https=) |
| CO (1) | CO2020000526A2 (https=) |
| EA (1) | EA202090069A1 (https=) |
| IL (1) | IL272138B2 (https=) |
| IT (1) | IT201700085412A1 (https=) |
| JO (1) | JOP20200012A1 (https=) |
| MA (1) | MA49794A (https=) |
| MX (1) | MX2020000806A (https=) |
| PE (1) | PE20200794A1 (https=) |
| PH (1) | PH12020550031A1 (https=) |
| WO (1) | WO2019021232A1 (https=) |
| ZA (1) | ZA202000461B (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201700089258A1 (it) | 2017-08-02 | 2019-02-02 | Pharmanutra S P A | Composizione per uso nella prevenzione e nel trattamento di carenza di ferro |
| WO2019237054A1 (en) | 2018-06-08 | 2019-12-12 | Epizon Pharma, Inc. | Methods and compositions for preventing or treating calciphylaxis |
| IL279245B2 (en) | 2018-06-08 | 2024-03-01 | Epizon Pharma Inc | Compositions comprising menaquinone-7 (mk-7) and/or menquinol for prophylaxis of tissue calcification |
| IT201900007326A1 (it) | 2019-05-27 | 2020-11-27 | Alesco Srl | Composizioni comprendenti acidi grassi cetilati e loro uso nel trattamento di artriti e stati infiammatori articolari |
| IT201900007311A1 (it) | 2019-05-27 | 2020-11-27 | Alesco Srl | Procedimento per la preparazione di una composizione comprendente acidi grassi cetilati |
| CN114748486A (zh) * | 2022-03-25 | 2022-07-15 | 南京盛德生物科技研究院有限公司 | 一种含有维生素k2改善心血管钙化的药物组合物及其制备方法与应用 |
| JP2025518284A (ja) | 2022-05-31 | 2025-06-12 | リージョン スイダンマーク | 冠動脈石灰化（ｃａｃ）の治療に使用するためのビタミンｋ２ |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3860849B2 (ja) * | 1994-04-28 | 2006-12-20 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗動脈硬化治療剤 |
| WO1996039053A2 (en) * | 1995-06-06 | 1996-12-12 | Campbell Soup Company | Mineral supplements for dietetic food |
| US6361800B1 (en) * | 2000-04-13 | 2002-03-26 | Cooper Concepts, Inc. | Multi-vitamin and mineral supplement |
| GB0220182D0 (en) * | 2002-08-30 | 2002-10-09 | Cardiovascular Res Inst Maastr | Organic compounds |
| WO2005044189A2 (en) * | 2003-10-28 | 2005-05-19 | Emory University | Dialysates and methods and systems related thereto |
| US20050281888A1 (en) * | 2004-06-16 | 2005-12-22 | Chandra Ranjit K | Nutritional supplement for infants |
| US20060134226A1 (en) * | 2004-11-16 | 2006-06-22 | Todd Leonard | Compositions useful to treat ocular neovascular diseases and macular degeneration |
| MX2008008009A (es) * | 2005-12-23 | 2008-09-12 | Ajay Gupta | Composicion de nutricion parenteral que contiene hierro. |
| JP2009525277A (ja) * | 2006-01-30 | 2009-07-09 | グロボアジア エルエルシー | 軟組織石灰化の回復、予防、遅延または安定化方法 |
| US20100021573A1 (en) * | 2008-07-22 | 2010-01-28 | Michael J Gonzalez | Compositions and methods for the prevention of cardiovascular disease |
| EP2380578A4 (en) * | 2008-12-25 | 2013-09-04 | Ibe Co Ltd | BIOACTIVE AGENT, PHARMACEUTICAL PRODUCT, COSMETIC PRODUCT, AGENT PRESERVING FRESHNESS AND AGENT PROMOTING PLANT AND ANIMAL GROWTH |
| PH12013502396A1 (en) * | 2011-05-20 | 2019-07-17 | Friesland Brands Bv | Composition comprising vitamin k2 |
| ITMI20121350A1 (it) * | 2012-07-31 | 2014-02-01 | Alesco Srl | Composizione solido a base di ferro per uso nelle condizioni di deficienza di ferro. |
| EP2886129A1 (en) * | 2013-12-20 | 2015-06-24 | VitaK B.V. | Prevention and counteraction of diet-induced thrombosis risk |
| WO2016131993A2 (en) * | 2015-02-20 | 2016-08-25 | Vitak B.V. | Vitamin k and capillary function |
| US11344575B2 (en) * | 2016-08-15 | 2022-05-31 | Summit Innovation Labs, LLC | Vascular calcification prevention and treatment |
-
2017
- 2017-07-26 IT IT102017000085412A patent/IT201700085412A1/it unknown
-
2018
- 2018-07-26 BR BR112020000902-4A patent/BR112020000902B1/pt not_active IP Right Cessation
- 2018-07-26 IL IL272138A patent/IL272138B2/en unknown
- 2018-07-26 EP EP18762623.9A patent/EP3657963A1/en not_active Withdrawn
- 2018-07-26 KR KR1020207001554A patent/KR20200032691A/ko not_active Ceased
- 2018-07-26 CN CN201880045110.6A patent/CN111031813A/zh active Pending
- 2018-07-26 EA EA202090069A patent/EA202090069A1/ru unknown
- 2018-07-26 PE PE2020000102A patent/PE20200794A1/es unknown
- 2018-07-26 WO PCT/IB2018/055586 patent/WO2019021232A1/en not_active Ceased
- 2018-07-26 US US16/631,426 patent/US20200206157A1/en not_active Abandoned
- 2018-07-26 MX MX2020000806A patent/MX2020000806A/es unknown
- 2018-07-26 CA CA3070659A patent/CA3070659A1/en active Pending
- 2018-07-26 JO JOP/2020/0012A patent/JOP20200012A1/ar unknown
- 2018-07-26 MA MA049794A patent/MA49794A/fr unknown
- 2018-07-26 JP JP2020502672A patent/JP2020528888A/ja active Pending
-
2020
- 2020-01-17 PH PH12020550031A patent/PH12020550031A1/en unknown
- 2020-01-17 CO CONC2020/0000526A patent/CO2020000526A2/es unknown
- 2020-01-20 CL CL2020000170A patent/CL2020000170A1/es unknown
- 2020-01-23 ZA ZA2020/00461A patent/ZA202000461B/en unknown
-
2023
- 2023-05-02 JP JP2023076299A patent/JP2023090869A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR112020000902B1 (pt) | 2024-03-12 |
| KR20200032691A (ko) | 2020-03-26 |
| PE20200794A1 (es) | 2020-08-10 |
| ZA202000461B (en) | 2021-03-31 |
| IT201700085412A1 (it) | 2019-01-26 |
| IL272138A (en) | 2020-03-31 |
| IL272138B1 (en) | 2023-05-01 |
| CO2020000526A2 (es) | 2020-02-18 |
| IL272138B2 (en) | 2023-09-01 |
| US20200206157A1 (en) | 2020-07-02 |
| WO2019021232A1 (en) | 2019-01-31 |
| EP3657963A1 (en) | 2020-06-03 |
| MX2020000806A (es) | 2020-08-17 |
| JP2023090869A (ja) | 2023-06-29 |
| CA3070659A1 (en) | 2019-01-31 |
| CN111031813A (zh) | 2020-04-17 |
| EA202090069A1 (ru) | 2020-04-10 |
| PH12020550031A1 (en) | 2021-02-08 |
| JP2020528888A (ja) | 2020-10-01 |
| BR112020000902A2 (pt) | 2020-07-21 |
| JOP20200012A1 (ar) | 2020-01-26 |
| MA49794A (fr) | 2020-06-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2020000170A1 (es) | Composición para su uso en la prevención y el tratamiento de patologías del aparato cardiovascular. | |
| GT201700072A (es) | Composiciones y métodos de uso para tratar trastornos metabólicos | |
| MX2019011061A (es) | Compuestos útiles en el tratamiento o prevención de un trastorno mediado por la proteína arginina metil-transferasa 5 (prmt5). | |
| CL2018000198A1 (es) | Composiciones de arni de transtiretina (ttr) y métodos para su uso para el tratamiento o prevencion de enfermedades asociadas con ttr | |
| CO2017001493A2 (es) | Kits que comprenden inhibidores tigit y agentes anticáncer | |
| MX2015013948A (es) | Composicion farmaceutica, metodos para tratamiento y sus usos. | |
| MX383164B (es) | Composicion que contiene arn para tratamiento de enfermedades tumorales. | |
| MX2019003363A (es) | Composiciones farmaceuticas para usarse en la terapia de la blefaritis. | |
| ECSP17077930A (es) | Métodos y kits para tratar la depresión | |
| BR112016014481A2 (pt) | tratamento de câncer utilizando combinações de inibidores de erk e raf | |
| MX381069B (es) | Profármacos de carbidopa y l-dopa y métodos de uso. | |
| CL2018000597A1 (es) | Métodos para tratar enfermedades inflamatorias | |
| BR112017009584A2 (pt) | tratamento de retinite pigmentosa com n-acetilcisteína amida | |
| BR112017007817A2 (pt) | tratamento do câncer com estimuladores imunológicos | |
| CL2017003066A1 (es) | Composiciones de carbonato de calcio amorfo para administración mediante inhalación, sublingual o bucal | |
| BR112018008882A2 (pt) | método para tratar um distúrbio proliferativo e produto farmacêutico | |
| MX2017005283A (es) | Nuevos derivados de pirazol en calidad de inhibidores de la cinasa inductora de nf-kb (nik). | |
| CL2015003343A1 (es) | Composición farmacéutica que comprende un agente terapéutico modificado en base a hemoglobina, para el tratamiento para tratar el cáncer, e imágenes de diagnóstico. | |
| MX2016011667A (es) | Composiciones topicas que comprenden un extracto de coriolus versicolor para aumentar la autoinmunidad. | |
| CL2019000018A1 (es) | Formas sólidas de un estimulador de sgc. | |
| MX388286B (es) | Formulaciones de oxitocina que contienen magnesio y metodos de uso. | |
| BR112016027043A8 (pt) | combinação, composição farmacêutica compreendendo glucocorticoide e edo-s101, kit e uso no tratamento de câncer | |
| BR112017018758A2 (pt) | alteração do metabolismo de esteroide para tratamento de doença dependente de esteroide | |
| MX2016007803A (es) | Composiciones de acidos grasos omega 3 para tratar enfermedades que implican daños al sistema nervioso. | |
| UY37729A (es) | NUEVOS COMPUESTOS QUE INHIBEN LA ACTIVIDAD DE Nav1.7 |